Ferah Yildirim

1.1k total citations
14 papers, 599 citations indexed

About

Ferah Yildirim is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Ferah Yildirim has authored 14 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Ferah Yildirim's work include Genetic Neurodegenerative Diseases (9 papers), Ubiquitin and proteasome pathways (6 papers) and Mitochondrial Function and Pathology (4 papers). Ferah Yildirim is often cited by papers focused on Genetic Neurodegenerative Diseases (9 papers), Ubiquitin and proteasome pathways (6 papers) and Mitochondrial Function and Pathology (4 papers). Ferah Yildirim collaborates with scholars based in Germany, United States and United Kingdom. Ferah Yildirim's co-authors include Christoph Harms, Andreas Meisel, David E. Housman, Ernest Fraenkel, Christopher Ng, Adam Labadorf, Golo Kronenberg, Matthias Endres, Klaus Fink and Karen Gertz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Neurochemistry.

In The Last Decade

Ferah Yildirim

13 papers receiving 596 citations

Peers

Countries citing papers authored by Ferah Yildirim

Since Specialization

Citations

This map shows the geographic impact of Ferah Yildirim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferah Yildirim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferah Yildirim more than expected).

Fields of papers citing papers by Ferah Yildirim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferah Yildirim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferah Yildirim. The network helps show where Ferah Yildirim may publish in the future.

Co-authorship network of co-authors of Ferah Yildirim

This figure shows the co-authorship network connecting the top 25 collaborators of Ferah Yildirim. A scholar is included among the top collaborators of Ferah Yildirim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferah Yildirim. Ferah Yildirim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Striatal transcriptome changes linked to drug‐induced repetitive behaviors 2021 ·European Journal of Neuroscience ·Jill R. Crittenden, Theresa A. Gipson, Anne C. Smith, (unknown), Ferah Yildirim, (unknown), (unknown), David E. Housman, Ann M. Graybiel	8
2	Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington’s disease 2021 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Nurcan Tunçbağ, Christian Rosenmund, Ferah Yildirim	15
3	The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice 2021 ·Frontiers in Molecular Neuroscience ·(unknown), Susanne Mueller, Stefan Koch, (unknown), (unknown), Christoph Harms, Philipp Boehm‐Sturm, Ferah Yildirim	22
4	A Systematic Review of Transcriptional Dysregulation in Huntington’s Disease Studied by RNA Sequencing 2021 ·Frontiers in Genetics ·(unknown), (unknown), (unknown), (unknown), Ferah Yildirim	38
5	Shared and oppositely regulated transcriptomic signatures in Huntington's disease and brain ischemia confirm known and unveil novel potential neuroprotective genes 2021 ·Neurobiology of Aging ·Ferah Yildirim, Marco Foddis, (unknown), Susanne Müller, (unknown), Manuel Holtgrewe, Vasilis Kola, Dieter Beule, Celeste Sassi	4
6	Synaptic control of DNA methylation involves activity-dependent degradation of DNMT3A1 in the nucleus 2020 ·Neuropsychopharmacology ·(unknown), PingAn Yuanxiang, (unknown), Guilherme M. Gomes, Syed Ahsan Raza, Oliver Stork, Shoji Tajima, Isao Suetake, Anna Karpova, Ferah Yildirim, Michael R. Kreutz	17
7	Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington’s disease 2019 ·Proceedings of the National Academy of Sciences ·Ferah Yildirim, Christopher Ng, Vincent Kappès, Tobias Ehrenberger, (unknown), (unknown), Theresa A. Gipson, Anthony R. Soltis, Peter Vanhoutte, Jocelyne Caboche, David E. Housman, Ernest Fraenkel	29
8	Inhibition of Histone Methyltransferases SUV39H1 and G9a Leads to Neuroprotection in an in vitro Model of Cerebral Ischemia 2015 ·Journal of Cerebral Blood Flow & Metabolism ·(unknown), Christoph Harms, (unknown), Jennifer Flynn, Jochen Hecht, Ferah Yildirim, Andreas Meisel, Stefanie Märschenz	38
9	Histone Acetylation and CREB Binding Protein Are Required for Neuronal Resistance against Ischemic Injury 2014 ·PLoS ONE ·Ferah Yildirim, Shengbo Ji, Golo Kronenberg, Ángel Barco, Román Olivares, Eva Benito, Ulrich Dirnagl, Karen Gertz, Matthias Endres, Christoph Harms, Andreas Meisel	42
10	Extensive changes in DNA methylation are associated with expression of mutant huntingtin 2013 ·Proceedings of the National Academy of Sciences ·Christopher Ng, Ferah Yildirim, Yoon Sing Yap, Simona Dalin, Bryan J. Matthews, Patricio Vélez, Adam Labadorf, David E. Housman, Ernest Fraenkel	129
11	Targeting H3K4 trimethylation in Huntington disease 2013 ·Proceedings of the National Academy of Sciences ·Malini Vashishtha, Christopher Ng, Ferah Yildirim, Theresa A. Gipson, Ian H. Kratter, László Bodai, Wan Song, Alice Lau, Adam Labadorf, Annie Vogel Ciernia, (unknown), Christopher A. Ross, Gillian P. Bates, Dimitri Krainc, Ghazaleh Sadri‐Vakili, Steven Finkbeiner, Joan Marsh, David E. Housman, Ernest Fraenkel, Leslie M. Thompson	130
12	Polyglutamine Expanded Huntingtin Dramatically Alters the Genome-Wide Binding of HSF1 2012 ·Journal of Huntington s Disease ·Laura Riva, Martina Koeva, Ferah Yildirim, Leila Pirhaji, (unknown), Tali Mazor, Martin L. Duennwald, Ernest Fraenkel	0
13	Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury 2007 ·Experimental Neurology ·Ferah Yildirim, Karen Gertz, Golo Kronenberg, Christoph Harms, Klaus Fink, Andreas Meisel, Matthias Endres	92
14	Inhibition of histone deacetylation protects wild‐type but not gelsolin‐deficient neurons from oxygen/glucose deprivation 2006 ·Journal of Neurochemistry ·Andreas Meisel, Christoph Harms, Ferah Yildirim, Julian Bösel, Golo Kronenberg, Ulrike Harms, Klaus Fink, Matthias Endres	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact